Corrigendum: ESR1 fusions and therapeutic resistance in metastatic breast cancer. 2023

Zsuzsanna Nagy, and Rinath Jeselsohn
Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.

[This corrects the article DOI: 10.3389/fonc.2022.1037531.].

UI MeSH Term Description Entries

Related Publications

Zsuzsanna Nagy, and Rinath Jeselsohn
August 2020, Breast cancer research : BCR,
Zsuzsanna Nagy, and Rinath Jeselsohn
January 2018, Molecular & cellular oncology,
Zsuzsanna Nagy, and Rinath Jeselsohn
February 2022, British journal of cancer,
Zsuzsanna Nagy, and Rinath Jeselsohn
January 2021, British journal of cancer,
Zsuzsanna Nagy, and Rinath Jeselsohn
January 2019, NPJ breast cancer,
Zsuzsanna Nagy, and Rinath Jeselsohn
August 2018, Cell reports,
Zsuzsanna Nagy, and Rinath Jeselsohn
February 2024, Cancer discovery,
Zsuzsanna Nagy, and Rinath Jeselsohn
December 2013, Nature genetics,
Copied contents to your clipboard!